| Product Code: ETC7219893 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 France Geographic Atrophy Market Overview |
3.1 France Country Macro Economic Indicators |
3.2 France Geographic Atrophy Market Revenues & Volume, 2021 & 2031F |
3.3 France Geographic Atrophy Market - Industry Life Cycle |
3.4 France Geographic Atrophy Market - Porter's Five Forces |
3.5 France Geographic Atrophy Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.6 France Geographic Atrophy Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.7 France Geographic Atrophy Market Revenues & Volume Share, By Therapeutic Agents Clinical Phase, 2021 & 2031F |
4 France Geographic Atrophy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of age-related macular degeneration (AMD) in France |
4.2.2 Growing geriatric population in France leading to higher incidence of geographic atrophy |
4.2.3 Advancements in healthcare technology and treatment options for geographic atrophy in France |
4.3 Market Restraints |
4.3.1 High cost of treatment and limited access to healthcare services for some segments of the population in France |
4.3.2 Regulatory challenges and approval processes for new geographic atrophy therapies in France |
5 France Geographic Atrophy Market Trends |
6 France Geographic Atrophy Market, By Types |
6.1 France Geographic Atrophy Market, By Age Group |
6.1.1 Overview and Analysis |
6.1.2 France Geographic Atrophy Market Revenues & Volume, By Age Group, 2021- 2031F |
6.1.3 France Geographic Atrophy Market Revenues & Volume, By Above 60 Years, 2021- 2031F |
6.1.4 France Geographic Atrophy Market Revenues & Volume, By Above 75 Years, 2021- 2031F |
6.2 France Geographic Atrophy Market, By Diagnosis |
6.2.1 Overview and Analysis |
6.2.2 France Geographic Atrophy Market Revenues & Volume, By Fundus Autofluorescence (FAF), 2021- 2031F |
6.2.3 France Geographic Atrophy Market Revenues & Volume, By Optical Coherence Tomography Angiography (OCT-A), 2021- 2031F |
6.2.4 France Geographic Atrophy Market Revenues & Volume, By Multifocal Electroretinography (MfERG), 2021- 2031F |
6.3 France Geographic Atrophy Market, By Therapeutic Agents Clinical Phase |
6.3.1 Overview and Analysis |
6.3.2 France Geographic Atrophy Market Revenues & Volume, By Late-Stage (Phase III), 2021- 2031F |
6.3.3 France Geographic Atrophy Market Revenues & Volume, By Phase II, 2021- 2031F |
6.3.4 France Geographic Atrophy Market Revenues & Volume, By Phase I, 2021- 2031F |
7 France Geographic Atrophy Market Import-Export Trade Statistics |
7.1 France Geographic Atrophy Market Export to Major Countries |
7.2 France Geographic Atrophy Market Imports from Major Countries |
8 France Geographic Atrophy Market Key Performance Indicators |
8.1 Average time from diagnosis to treatment initiation for geographic atrophy patients in France |
8.2 Patient satisfaction with available treatment options for geographic atrophy in France |
8.3 Percentage of healthcare professionals trained in diagnosing and treating geographic atrophy in France |
9 France Geographic Atrophy Market - Opportunity Assessment |
9.1 France Geographic Atrophy Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.2 France Geographic Atrophy Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.3 France Geographic Atrophy Market Opportunity Assessment, By Therapeutic Agents Clinical Phase, 2021 & 2031F |
10 France Geographic Atrophy Market - Competitive Landscape |
10.1 France Geographic Atrophy Market Revenue Share, By Companies, 2024 |
10.2 France Geographic Atrophy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here